» Articles » PMID: 18971481

Cell Death After Spinal Cord Injury is Exacerbated by Rapid TNF Alpha-induced Trafficking of GluR2-lacking AMPARs to the Plasma Membrane

Overview
Journal J Neurosci
Specialty Neurology
Date 2008 Oct 31
PMID 18971481
Citations 128
Authors
Affiliations
Soon will be listed here.
Abstract

Glutamate, the major excitatory neurotransmitter in the CNS, is implicated in both normal neurotransmission and excitotoxicity. Numerous in vitro findings indicate that the ionotropic glutamate receptor, AMPAR, can rapidly traffic from intracellular stores to the plasma membrane, altering neuronal excitability. These receptor trafficking events are thought to be involved in CNS plasticity as well as learning and memory. AMPAR trafficking has recently been shown to be regulated by glial release of the proinflammatory cytokine tumor necrosis factor alpha (TNFalpha) in vitro. This has potential relevance to several CNS disorders, because many pathological states have a neuroinflammatory component involving TNFalpha. However, TNFalpha-induced trafficking of AMPARs has only been explored in primary or slice cultures and has not been demonstrated in preclinical models of CNS damage. Here, we use confocal and image analysis techniques to demonstrate that spinal cord injury (SCI) induces trafficking of AMPARs to the neuronal membrane. We then show that this effect is mimicked by nanoinjections of TNFalpha, which produces specific trafficking of GluR2-lacking receptors which enhance excitotoxicity. To determine if TNFalpha-induced trafficking affects neuronal cell death, we sequestered TNFalpha after SCI using a soluble TNFalpha receptor, and significantly reduced both AMPAR trafficking and neuronal excitotoxicity in the injury penumbra. The data provide the first evidence linking rapid TNFalpha-induced AMPAR trafficking to early excitotoxic secondary injury after CNS trauma in vivo, and demonstrate a novel way in which pathological states hijack mechanisms involved in normal synaptic plasticity to produce cell death.

Citing Articles

Cellular signaling pathways in the nervous system activated by various mechanical and electromagnetic stimuli.

Ryu Y, Wague A, Liu X, Feeley B, Ferguson A, Morioka K Front Mol Neurosci. 2024; 17:1427070.

PMID: 39430293 PMC: 11486767. DOI: 10.3389/fnmol.2024.1427070.


Astrocytes originated from neural stem cells drive the regenerative remodeling of pathologic CSPGs in spinal cord injury.

Hosseini S, Nemati S, Karimi-Abdolrezaee S Stem Cell Reports. 2024; 19(10):1451-1473.

PMID: 39303705 PMC: 11561464. DOI: 10.1016/j.stemcr.2024.08.007.


Improving rigor and reproducibility in western blot experiments with the blotRig analysis.

Omondi C, Chou A, Fond K, Morioka K, Joseph N, Sacramento J Sci Rep. 2024; 14(1):21644.

PMID: 39284854 PMC: 11405887. DOI: 10.1038/s41598-024-70096-0.


Neuroprotective and anti-inflammatory properties of proteins secreted by glial progenitor cells derived from human iPSCs.

Salikhova D, Shedenkova M, Sudina A, Belousova E, Krasilnikova I, Nekrasova A Front Cell Neurosci. 2024; 18:1449063.

PMID: 39165834 PMC: 11333358. DOI: 10.3389/fncel.2024.1449063.


A review of dorsal root ganglia and primary sensory neuron plasticity mediating inflammatory and chronic neuropathic pain.

Jang K, Garraway S Neurobiol Pain. 2024; 15:100151.

PMID: 38314104 PMC: 10837099. DOI: 10.1016/j.ynpai.2024.100151.


References
1.
Lissin D, Gomperts S, Carroll R, Christine C, Kalman D, Kitamura M . Activity differentially regulates the surface expression of synaptic AMPA and NMDA glutamate receptors. Proc Natl Acad Sci U S A. 1998; 95(12):7097-102. PMC: 22752. DOI: 10.1073/pnas.95.12.7097. View

2.
Tobinick E, Gross H . Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration. J Neuroinflammation. 2008; 5:2. PMC: 2211476. DOI: 10.1186/1742-2094-5-2. View

3.
Skeberdis V, Lan J, Zheng X, Zukin R, Bennett M . Insulin promotes rapid delivery of N-methyl-D- aspartate receptors to the cell surface by exocytosis. Proc Natl Acad Sci U S A. 2001; 98(6):3561-6. PMC: 30692. DOI: 10.1073/pnas.051634698. View

4.
Beattie E, Stellwagen D, Morishita W, Bresnahan J, Ha B, Von Zastrow M . Control of synaptic strength by glial TNFalpha. Science. 2002; 295(5563):2282-5. DOI: 10.1126/science.1067859. View

5.
Walters M, Kaste M, Lees K, Diener H, Hommel M, De Keyser J . The AMPA antagonist ZK 200775 in patients with acute ischaemic stroke: a double-blind, multicentre, placebo-controlled safety and tolerability study. Cerebrovasc Dis. 2005; 20(5):304-9. DOI: 10.1159/000087929. View